You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endothelial Growth Factors

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveitis, Cystoid Macular Edema Trial in Winston-Salem (Pegaptanib)

Completed
Has Results
  • Uveitis
  • Cystoid Macular Edema
  • Winston-Salem, North Carolina
    Wake Forest University Eye Center
Mar 7, 2022

Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (Chemotherapy plus apatinib)

Completed
  • Recurrent Cervical Carcinoma
  • +5 more
  • Chemotherapy plus apatinib
  • Beijing, Beijing, China
    Lei Li
Mar 12, 2022

Pre-eclampsia, Intra-uterine Growth Retardation Trial in Grenoble (blood sample and doppler Ultrasound of uterine arteries)

Completed
  • Pre-eclampsia
  • Intra-uterine Growth Retardation
  • blood sample and doppler Ultrasound of uterine arteries
  • Grenoble, Isere, France
    Clinical investigation center of the Grenoble University Hospita
Aug 27, 2021

Glaucoma, Neovascular, Vascular Endothelial Growth Factor Overexpression Trial in Hat-yai (Intracameral injection, Intravitreal

Recruiting
  • Glaucoma, Neovascular
  • Vascular Endothelial Growth Factor Overexpression
  • Intracameral injection
  • Intravitreal injection
  • Hat-yai, Songkhla, Thailand
    Glaucoma unit , Department of Ophthalmology Faculty of Medicine
Feb 3, 2022

Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb

Recruiting
  • Age Related Macular Degeneration
  • recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
  • Xuzhou, Jiangsu, China
    XuZhou Central Hospital
Feb 7, 2022

Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal

Recruiting
  • Diabetic Macular Edema
  • +3 more
  • Intravitreal ranibizumab
  • Intravitreal bevacizumab
  • Cairo, Egypt
    Cairo University
Nov 26, 2021

Solid Tumor Trial in Shanghai (HB002.1T)

Completed
  • Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Jul 26, 2021

Vascular Endothelial Factor Gene Polymorphism in Preeclampsia

Completed
  • Preeclampsia
  • PCR
  • Doppler ultrasound
  • Cairo, Beni-Suef, Egypt
    Beni-Suef University
Mar 24, 2021

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Obstructive Sleep Apnea Trial in Shatin (Continuous positive airway pressure (CPAP), Sham Continuous positive airway pressure

Completed
  • Obstructive Sleep Apnea
  • Continuous positive airway pressure (CPAP)
  • Sham Continuous positive airway pressure (CPAP)
  • Shatin, New Territories, Hong Kong
    The Chinese University of Hong Kong
Jan 25, 2021

Retinal Pigment Epithelium Detachment in Neovascular Age-related

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Anti-vascular endothelial growth factor therapy
  • Krasnodar, Russian Federation
    The S.N. Fyodorov Eye Microsurgery State Institution
Jan 12, 2022

Intraocular Pressure, Neovascular Glaucoma, Vascular Endothelial Growth Factor Overexpression Trial in Bangkoknoi (Aflibercept

Completed
  • Intraocular Pressure
  • +3 more
  • Aflibercept Ophthalmic
  • Bangkoknoi, Bangkok, Thailand
    Naris Kitnarong
Jul 11, 2021

Uveal Melanoma Trial in Philadelphia (Stereotactic Body Radiation Therapy, Ziv-Aflibercept)

Recruiting
  • Uveal Melanoma
  • Stereotactic Body Radiation Therapy
  • Ziv-Aflibercept
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 13, 2021

Inverted Papilloma, Molecular Fluorescence Imaging Trial in Groningen (Bevacizumab-800CW)

Active, not recruiting
  • Inverted Papilloma
  • Molecular Fluorescence Imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 30, 2021

Hepatic Metastases, Colon Cancer, Rectal Cancer Trial in United States (Bevacizumab HAI plus systemic chemo, HAI plus systemic

Active, not recruiting
  • Hepatic Metastases
  • +2 more
  • Bevacizumab HAI plus systemic chemotherapy
  • HAI plus systemic chemotherapy
  • Basking Ridge, New Jersey
  • +4 more
Apr 26, 2022

Utilization of Cabozantinib in Adult Advanced or Metastatic

Withdrawn
  • Renal Cell Carcinoma
    • (no location specified)
    Dec 17, 2020

    Vascular Endothelial Growth Factor and Endostatin in

    Completed
    • Acute Ischemic Stroke
      • Shanghai, China
        Shanghai Sixth People's Hospital
      Aug 8, 2020

      Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

      Recruiting
      • Recurrent Fallopian Tube Carcinoma
      • +2 more
      • Bevacizumab
      • +4 more
      • Phoenix, Arizona
      • +2 more
      Jun 27, 2022

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Completed
      Has Results
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +8 more
      • Bevacizumab
      • Irinotecan Sucrosofate
      • Chicago, Illinois
        Northwestern University
      Dec 21, 2022

      Coronary Artery Disease Trial (AdVEGF-All6A+, AdNull)

      Withdrawn
      • Coronary Artery Disease
      • AdVEGF-All6A+
      • AdNull
      • (no location specified)
      Jan 24, 2021

      Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

      Recruiting
      • Resectable Hepatocellular Carcinoma
      • +4 more
      • Atezolizumab
      • +2 more
      • Houston, Texas
      • +1 more
      Oct 12, 2022

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

      Recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +5 more
      • Bevacizumab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 13, 2022

      Eyes That Do Not Meet Eligibility Criteria of Clinical Trials on

      Completed
      • Age-related Macular Degeneration
      • Intravitreal anti-vascular endothelial growth factor injection
      • Seoul, Korea, Republic of
        Jae Hui Kim
      Apr 6, 2021

      Neovascular Age-Related Macular Degeneration Trial in Shanghai (HB002.1M)

      Completed
      • Neovascular Age-Related Macular Degeneration
      • Shanghai, Shanghai, China
        Shanghai General Hospital
      Jul 28, 2020

      Age Related Macular Degeneration Trial (LY09004, Eylea)

      Not yet recruiting
      • Age Related Macular Degeneration
      • (no location specified)
      Sep 25, 2020